Advanced BioPhotonics, Yale announce infrared imaging pilot program
Advanced BioPhotonics, Inc., a developer of medical imaging applications using advanced infrared technology, announced this week a one-year pilot site agreement with Yale University School of Medicine's Department of Surgery. The project will investigate the use of Advanced BioPhotonics' DIRI brand of dynamic infrared imaging in mapping vascular perforator vessels and post-op monitoring of flap viability in reconstructive breast surgery.
"Based on earlier work done at the University of Geneva, the company believes that perforator vessel localization represents a very promising application where we may be able to demonstrate faster and more accurate vascular assessment," said Denis O'Connor, CEO, Advanced BioPhotonics. "We feel that this application represents a very important early market for our BioScanIR product and are delighted to be working with an institution as prestigious as Yale University School of Medicine in this area."
During the study which is set to begin this month, Yale will use the company’s BioScanIR System, a functional medical imaging modality which provides a non-invasive, radiation-free method for detecting diseases that affect blood perfusion.
"Based on earlier work done at the University of Geneva, the company believes that perforator vessel localization represents a very promising application where we may be able to demonstrate faster and more accurate vascular assessment," said Denis O'Connor, CEO, Advanced BioPhotonics. "We feel that this application represents a very important early market for our BioScanIR product and are delighted to be working with an institution as prestigious as Yale University School of Medicine in this area."
During the study which is set to begin this month, Yale will use the company’s BioScanIR System, a functional medical imaging modality which provides a non-invasive, radiation-free method for detecting diseases that affect blood perfusion.